Cite
HARVARD Citation
Habtewold, A. et al. (2015). Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study. Pharmacogenomics. pp. 1047-1064. [Online].